Skip to Content

Trulicity Approval History

FDA Approved: Yes (First approved September 18, 2014)
Brand name: Trulicity
Generic name: dulaglutide
Dosage form: Injection
Company: Eli Lilly and Company
Treatment for: Diabetes, Type 2

Trulicity (dulaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of type 2 diabetes.

Development History and FDA Approval Process for Trulicity

DateArticle
Sep 18, 2014Approval FDA Approves Trulicity (dulaglutide) for Type 2 Diabetes

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide